Related Experiment Video
Updated: Jul 16, 2026

Metagenomic Next-Generation Sequencing of Cerebrospinal Fluid for the Detection of Central Nervous System Pathogens
Published on: April 17, 2026
Linezolid cerebrospinal fluid concentration in central nervous system infection
P Malacarne1, B Viaggi, A DI Paolo
1U.O. Anestesia e Rianimazione, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy. pmalacarne@hotmail.com
Abstract:
We report two cases of central nervous system infection due to methicillin-resistant Staphylococcus epidermidis treated with linezolid. The first case was a 72-year old woman with ventriculitis in the presence of intraventricular catheter: therapeutic effectiveness was documented clinically and microbiologically; serum and cerebrospinal fluid levels were measured after the first and fourth doses: trough linezolid concentrations in cerebrospinal fluid were 1.44 and 2.9 mg/L respectively, higher than the minimum inhibitory concentration (MIC). The second case was a 27-year old man with post-traumatic cerebral abscess; during 5 days linezolid was not found in his cerebrospinal fluid despite very high serum level peak, and the drug was not detectable in cerebral tissue surgically removed after 14 days of therapy. Linezolid may not reach therapeutic concentrations in cerebrospinal fluid, and, when possible, we suggest that drug levels be monitored.
Insights
Linezolid effectively treated central nervous system infections in one case but failed to reach therapeutic cerebrospinal fluid concentrations in another. Monitoring drug levels is recommended for linezolid in CNS infections.
Area of Science:
- Infectious Diseases
- Neuroscience
- Pharmacology
Background:
- Central nervous system (CNS) infections require effective antimicrobial therapy.
- Methicillin-resistant Staphylococcus epidermidis (MRSE) can cause severe CNS infections.
- Linezolid is a potential treatment option for resistant bacterial infections.
Observation:
- Two cases of MRSE CNS infections treated with linezolid are presented.
- Case 1: A 72-year-old woman with ventriculitis showed clinical and microbiological improvement with linezolid.
- Case 2: A 27-year-old man with a cerebral abscess did not achieve detectable cerebrospinal fluid (CSF) linezolid levels despite high serum concentrations.
Findings:
- Linezolid achieved therapeutic concentrations in CSF in the first case (trough levels > MIC).
- Linezolid was undetectable in CSF and cerebral tissue in the second case, despite high serum levels.
- This suggests variable penetration of linezolid into the CNS.
Implications:
- Linezolid's efficacy in CNS infections may be limited by poor CSF penetration.
- Monitoring of linezolid drug levels in CSF is crucial for optimizing treatment in CNS infections.
- Further research is needed to understand factors influencing linezolid's CNS penetration and to guide its use in neuroinfectious diseases.
Related Concept Videos
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Cryptococcal Meningitis
Cerebrospinal Fluid
CSF Production
CSF is produced mainly in the choroid plexus, a network of capillaries and ependymal cells located within the ventricular system of the brain.
Brain Abscess l: Introduction
Bacterial Meningitis II: Pathophysiology
